DSIJ Mindshare

API business opportunities push Aarti Drugs; stock zooms 132 per cent in 6 months

Nidhi Jani 0 4302 Article rating: 4.2

Currently, India imports over 60 per cent of its APIs consumption from China and other countries, which opens up significant opportunities for Indian API manufacturers like Aarti Drugs. The company has geared up its API production by nearly 44 per cent to 25,591 MT in FY20.

RSS
First59215922592359245926592859295930Last
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR